Guidelines of care for superficial mycotic infections of the skin: Mucocutaneous candidiasis

Journal of the American Academy of Dermatology

Volumn 34, Issue 1, 1996, Pages 110-115

  Drake, Lynn A ^b   Dinehart, Scott M ^b   Farmer, Evan R ^b   Goltz, Robert W ^b   Graham, Gloria F ^b   Hordinsky, Maria K ^b   Lewis, Charles W ^b   Pariser, David M ^b   Skouge, John W ^b   Webster, Stephen B ^b   Whitaker, Duane C ^b   Butler, Barbara ^b   Lowery, Barbara J ^b   Elewski, B E ^a   Elgart, M L ^a   Jacobs, P H ^a   Lesher Jr , J L ^a   Scher, R K ^a  

^a AMERICAN ACADEMY OF DERMATOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CORTICOSTEROID; CRYSTAL VIOLET; ECONAZOLE; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NAFTIFINE; NYSTATIN; OXICONAZOLE; POLYENE ANTIBIOTIC AGENT; SULCONAZOLE; TERBINAFINE; TERCONAZOLE; TRIAZOLE DERIVATIVE;

CANDIDA ALBICANS; CANDIDIASIS; DERMATOMYCOSIS; DIAGNOSTIC TEST; DRUG PREFERENCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; TOPICAL DRUG ADMINISTRATION; TREATMENT INDICATION;

EID: 13344261962     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90842-7     Document Type: Article

References (17)

1. Bickers DR. Antifungal therapy: potential interactions with other classes of drugs. J AM ACAD DERMATOL 1994;31:S87-S90.
2. Bodey GP. Candidiasis in cancer patients. Am J Med 1984; 77(4D):13-9.
3. Bodey GP, Samonis G, Rolston K. Prophylaxis of candidiasis in cancer patients. Semin Oncol 1990;17:24-8.
4. Brodell RT, Elewski BE. Clinical pearl: systemic antifungal drugs and drug interactions. J AM ACAD DERMATOL 1995;33:259-60.
5. Burke WA. Use of itraconazole in a patient with chronic mucocutaneous candidiasis. J AM ACAD DERMATOL 1989;21:1309-10.
6. Coldiron BM, Manders SM. Persistent Candida intertrigo treated with fluconazole. Arch Dermatol 1991;127:165-6.
7. Greenspan D. Treatment of oropharyngeal candidiasis in HIV-positive patients. J AM ACAD DERMATOL 1994;31:S51-S5.
8. Hay RJ. Antifungal drugs on the horizon. J AM ACAD DERMATOL 1994;31:S82-S5.
9. Hay RJ. Antifungal therapy of yeast infections. J AM ACAD DERMATOL 1994;31:S6-S9.
10. Kalb RE, Grossman ME. Ectodermal defects and chronic mucocutaneous candidiasis in idiopathic hypoparathyroidism. J AM ACAD DERMATOL 1986;15:353-6.
11. Kirkpatrick CH. Chronic mucocutaneous candidiasis. J AM ACAD DERMATOL 1994;31:S14-87.
12. Kirkpatrick CH, Sohnle PG. Chronic mucocutaneous candidiasis. In: Safai B, Good RA, eds. Immunodermatology. New York: Plenum Medical, 1981:495-514.
13. Lesher JL Jr, Smith JG Jr. Antifungal agents in dermatology. J AM ACAD DERMATOL 1987;17:383-94.
14. Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
15. Physicians' Desk Reference. Montvale, NJ: Medical Economics, 1995.
16. Sobel JD. Controversial aspects in the management of vulvovaginal candidiasis. J AM ACAD DERMATOL 1994;31:S10-S3.
17. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.